NIPT for High-Risk Pregnancies: What Expectant Parents Should Know

Non-invasive prenatal testing, commonly called NIPT, provides expectant parents with early information about the likelihood of certain chromosomal conditions. Although NIPT may be offered during any pregnancy, it can be especially helpful when a pregnancy is considered high risk and additional screening information may guide prenatal care.

What Does NIPT Screen For?

NIPT is a blood test that analyzes small fragments of cell-free DNA circulating in the pregnant patient’s bloodstream. Most of this genetic material comes from the placenta and usually reflects the developing baby’s chromosomes.

The screening primarily evaluates the likelihood of common chromosomal conditions, including:

•          Trisomy 21, also known as Down syndrome

•          Trisomy 18, also known as Edwards syndrome

•          Trisomy 13, also known as Patau syndrome

•          Certain sex chromosome differences, when included in the selected test

NIPT can generally be performed starting at 10 weeks of pregnancy. Current clinical guidance recognizes cell-free DNA screening as the most sensitive and specific screening option for common fetal trisomies.

Why NIPT May Be Discussed in a High-Risk Pregnancy

A pregnancy may be classified as high risk because of maternal age, previous pregnancy history, family history, ultrasound findings, multiple gestation, or an existing health condition. These factors do not necessarily mean that the baby has a chromosomal condition, but they may lead an obstetrician to recommend earlier or more detailed screening discussions.

Patients carrying twins or who have experienced a vanishing twin may need additional counseling because these circumstances can affect how NIPT results are interpreted. The right screening approach should always reflect the patient’s medical history and individual pregnancy.

NIPT Is a Screening Test, Not a Diagnosis

One of the most important things expectant parents should understand is that NIPT estimates risk. A high-risk result does not confirm that the baby has a chromosomal condition, and a low-risk result cannot rule out every genetic disorder, birth defect, or pregnancy complication.

When NIPT shows an increased risk, additional testing may be recommended. Chorionic villus sampling or amniocentesis can examine fetal cells and provide a more definitive diagnosis. Genetic counseling may also help parents understand the result, available testing options, and possible next steps.

Preparing for Your Screening Discussion

Before choosing NIPT, talk with your obstetrician about what the selected panel screens for, what the results may mean, and whether insurance coverage should be confirmed. Patients also have the right to accept or decline prenatal genetic screening after receiving clear information about its benefits and limitations.

NIPT does not replace routine prenatal visits, ultrasound imaging, or other recommended testing. Instead, it can be one part of a personalized prenatal care plan designed to provide useful information while supporting informed decisions throughout pregnancy.

Schedule a prenatal care appointment with Partners in Obstetrics & Women’s Health to discuss whether NIPT is appropriate for your pregnancy. Visit our office in New Lenox, IL, or call (815) 240-0554 to book an appointment.